We need some solid press releases from BioSante bolstering and rebuilding some of the confidence that it shattered through its Libigel condundrum. We could also use some realistic projections on how BPAX intends to service its debt and continue as not only a going concern, but a growing, vibrant, profitable company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.